Etiometry Earns Top Honors – Major Recognition Nearby and Nationally

News and Press Releases

BOSTON, December 17, 2018 – Improving the quality of critical care has always been their top priority but earning accolades along the way is an added bonus. In 2018, Etiometry earned major recognition and funding from prestigious organizations nearby and nationally. 

Competing against 213 companies from five of the six New England states can be a daunting task for any business owner; but Etiometry was up for the challenge. After narrowing the competition to 50 semi-finalists, then 20 finalists, Etiometry’s COO Evan Butler presented the company’s mission in front of a 64-judge panel. Several months of deliberation went by but, ultimately, Etiometry took top honors as one of the eight winners of the 2018 New England Business Association’s Innovation Awards. “As the Circle of Excellence welcomes the class of 2018, I can honestly say it is one of our best yet”, said New England Innovation Awards Committee Chairman, Todd Faber, President, The Faber Group, in a press release.

The largest source of funding for medical research in the world continues to see value in Etiometry’s work. For the third time in four years, The National Institutes of Health awarded Etiometry nearly one million dollars to continue their groundbreaking progress in dynamic analytics for critical care facilities. The latest grant award aims to investigate how Etiometry’s FDA-cleared Risk Analytics Algorithm for Inadequate Delivery of Oxygen, known as the IDO2 Index, can best be used to inform treatment decisions. With the help of their clinical partners, the team is designing and deploying protocols and studying their critical care outcomes; such as length of stay, time on ventilation, and ECMO events. As a Boston-based company, Etiometry is proud to contribute to the city’s unparalleled 23-year record for most NIH funds.

About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.

For more information, visit www.etiometry.com.

We’d love to hear from you

Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.

Contact Us

Related

Keys to Success for AI Tool Adoption in Pediatric Critical Care

For successful adoption of AI tools in clinical care, health system and hospital clinicians should collaborate with the commercial developers of the technology. Read more about Dr. Gazit’s experience using Etiometry’s AI-driven clinical intelligence platform and how it supports confident decision-making in the ICU: HERE 

Etiometry 2025 Highlights and Looking Ahead to 2026

Etiometry is proud to celebrate a year of meaningful achievements in 2025, driven by close collaboration and a shared commitment to improving patient care.In 2025, Etiometry achieved significant momentum in advancing AI-driven clinical intelligence and supporting critical care teams: 2025 Highlights: As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven […]

Etiometry’s AI Platform Drives Measurable Outcomes as Hospitals Face Unprecedented Pressures

From platform advancement and expanding hospital adoption to award-winning innovation, Etiometry sets its sights on transforming patient care in 2026 BOSTON, Mass. – January 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, celebrates a year of significant achievements in 2025 and announces its vision to continue transforming critical care in the year ahead. In […]